Trends in non-receipt of recommended COPD medication

Michael Poon; Priscila Pequeno; Shawn D. Aaron; Matthew B. Stanbrook; Harvey H. Wong; Peter Cram; Andrea S. Gershon

doi:10.1183/23120541.00584-2021

Trends in non-receipt of recommended COPD medication

Michael Poon, Priscila Pequeno, Shawn D. Aaron, Matthew B. Stanbrook, Harvey H. Wong, Peter Cram, Andrea S. Gershon

ERJ Open Research 2022 8: 00584-2021; DOI: 10.1183/23120541.00584-2021

Michael Poon

1Dept of Medicine, University of Toronto, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Priscila Pequeno

2ICES, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shawn D. Aaron

3Ottawa Hospital Research Institute, Ottawa, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthew B. Stanbrook

1Dept of Medicine, University of Toronto, Toronto, ON, Canada

2ICES, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Harvey H. Wong

1Dept of Medicine, University of Toronto, Toronto, ON, Canada

4Dept of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Cram

1Dept of Medicine, University of Toronto, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Peter Cram

Andrea S. Gershon

1Dept of Medicine, University of Toronto, Toronto, ON, Canada

2ICES, Toronto, ON, Canada

4Dept of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Andrea S. Gershon
For correspondence: andrea.gershon@sunnybrook.ca

Article
Figures & Data
Info & Metrics
PDF

Figures

Download figure
Open in new tab
Download powerpoint
FIGURE 1
Age–sex-standardised proportion of people with chronic obstructive pulmonary disease aged ≥66 years at a) low risk of exacerbation who received a long-acting β₂-agonist (LABA) or long-acting anticholinergic bronchodilator, alone or in combination, and b) high risk of exacerbation who received both an inhaled corticosteroid and LABA or long-acting anticholinergic bronchodilator, in Ontario, 2004–2018.

PreviousNext

Vol 8 Issue 2 Table of Contents

Table of Contents
Index by author

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Trends in non-receipt of recommended COPD medication

Message Subject (Your Name) has sent you a message from European Respiratory Society

Message Body (Your Name) thought you would like to see the European Respiratory Society web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.